JS

Jyoti Sahay

Active Director Director DIN 07214939
DIN 07214939 First appointment Jul 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Jyoti Sahay

Data last updated:

Jyoti Sahay is a Director at Arunnya Biotech Private Limited (since 2015). The company operates in Healthcare. Arunnya Biotech Private Limited reported revenue of ₹2.83 Cr (FY 2024).

DIN 07214939
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2015
Oldest Company Age 11 yrs
Largest company Arunnya Biotech Private Limited · ₹2.83 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arunnya Biotech Private Limited U74900HR2015PTC055945
Director01 Jul 20152015₹2.83 Cr (FY 2024)Active

Board colleagues of Jyoti Sahay

NameDINCompanyDesignation
Niraj Varma06947972Arunnya Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arunnya Biotech Private Limited
Premium access

Shareholding and investment profile for Jyoti Sahay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Sahay

Jyoti Sahay currently holds 1 directorship: Arunnya Biotech Private Limited (Director, since 01 Jul 2015, revenue ₹2.83 Cr (FY 2024)).

Jyoti Sahay was first appointed on 01 Jul 2015 as Director at Arunnya Biotech Private Limited.

The current boards of Jyoti Sahay's companies include Niraj Varma (Arunnya Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available